No Data
No Data
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Express News | Sandoz Gains European Commission Approval For Afqlir (Aflibercept), Targeting Wider Access Biosimilars In Europe
FDA Accepts Organon BLA for Prolia/Xgeva Biosimilar
Express News | Sandoz Raised Its 2024 Net Sales Growth Guidance To High-Single Digits In Constant Currency; Maintains Core EBITDA Margin Guidance At ~20%
Sandoz US Launches Generic Paclitaxel in Single-dose Vial, Further Expanding US Oncology Portfolio
U.S. Government to Release Preliminary List for Pilot Medicare Program Offering Generics Under $2 - Report
No Data